These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31377459)

  • 1. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is It Possible to Develop a Prediction Model for Lymphovascular Space Invasion in Endometrioid Endometrial Cancer?
    Meydanli MM; Aslan K; Öz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
    Int J Gynecol Pathol; 2020 May; 39(3):213-220. PubMed ID: 31033799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
    Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
    Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus.
    Sarı ME; Meydanlı MM; Yalçın I; Şahin H; Çoban G; Çelik H; Kuşçu E; Gungor T; Ayhan A
    Oncol Res Treat; 2018; 41(12):750-754. PubMed ID: 30419557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.
    Korkmaz V; Meydanli MM; Yalçın I; Sarı ME; Sahin H; Kocaman E; Haberal A; Dursun P; Güngör T; Ayhan A
    J Gynecol Oncol; 2017 Nov; 28(6):e78. PubMed ID: 29027396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
    AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
    Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
    Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
    Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients.
    Kong TW; Kim J; Kim J; Lee J; Kim J; Son JH; Chang SJ
    J Gynecol Oncol; 2024 Jul; 35(4):e53. PubMed ID: 38302726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
    Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
    Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer.
    Cox Bauer CM; Greer DM; Kram JJF; Kamelle SA
    Gynecol Oncol; 2016 May; 141(2):199-205. PubMed ID: 26905210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
    Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS
    Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
    Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
    Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer.
    Lee J; Kong TW; Paek J; Chang SJ; Ryu HS
    Int J Gynecol Cancer; 2016 Nov; 26(9):1630-1635. PubMed ID: 27654258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
    Akbayir O; Corbacioglu A; Goksedef BP; Numanoglu C; Akca A; Guraslan H; Bakir LV; Cetin A
    Gynecol Oncol; 2012 May; 125(2):400-3. PubMed ID: 22310644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Predictive Model Using Histopathologic Characteristics of Early-Stage Type 1 Endometrial Cancer to Identify Patients at High Risk for Lymph Node Metastasis.
    Bendifallah S; Canlorbe G; Laas E; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Cortez A; Bleu G; Daraï E; Ballester M
    Ann Surg Oncol; 2015 Dec; 22(13):4224-32. PubMed ID: 25869227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Para-aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis.
    Baiocchi G; Faloppa CC; Mantoan H; Camarço WR; Badiglian-Filho L; Kumagai LY; De Brot L; da Costa AABA
    J Surg Oncol; 2017 Aug; 116(2):220-226. PubMed ID: 28482122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.